The D³ Ultra DFA (direct fluorescent antibody) Respiratory Virus Screening and Identification Kit is intended for the qualitative detection and identification of seven major respiratory viruses (influenza A, influenza B, respiratory syncytial virus (RSV), adenovirus, parainfluenza 1, parainfluenza 2 and parainfluenza 3 viruses) in respiratory specimens, by either direct detection or cell culture method, by immunofluorescence using fluoresceinated monoclonal antibodies (MAbs). It is recommended that specimens found to be negative after examination of the direct specimen result be confirmed by cell culture. Negative results do not preclude respiratory virus infection and should not be used as the sole basis for diagnosis, treatment or other management decisions.

Improve laboratory workflow and patient care with the D³ Ultra DFA Respiratory Virus Screening and Identification Kit.

• High-quality ­antibodies ­developed at the Quidel Hybridoma ­facility
• For rapid, sensitive and specific screening and definitive identification of Influenza A, Influenza B, Parainfluenza 1, 2, and 3, Respiratory Syncytial Virus and Adenovirus from direct patient specimens or culture
• One-step direct detection kit with a fifteen-minute ­incubation
• Improves workflow and laboratory time to result